Starpharma Holdings Ltd
SWB:PQ6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Starpharma Holdings Ltd (PQ6) under the Base Case is EUR per share.
Compared with the current market price of 0.26 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 4 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Starpharma Does
Starpharma Holdings Ltd is a biotechnology company that develops and commercializes dendrimer-based products. Its best-known products are its antiviral and antibacterial gels and coatings, including women’s health products and disinfectant or surface-treatment technologies. In simple terms, it uses its chemistry platform to make products that can block germs or carry active ingredients in a more targeted way.
- Headquarters
- Australia AU
- Employees
- 50
- IPO date
- Sep 28, 2000
Earnings Waterfall
Starpharma Holdings Ltd
What is the Intrinsic Value of one PQ6 stock?
The intrinsic value for Starpharma Holdings Ltd (PQ6) under the Base Case is EUR.
Is PQ6 stock undervalued or overvalued?
Compared with the current market price of 0.26 EUR, the stock appears .
